Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41598-018-30290-3
DC FieldValue
dc.titleFormulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)
dc.contributor.authorKoh K.J.
dc.contributor.authorLiu Y.
dc.contributor.authorLim S.H.
dc.contributor.authorLoh X.J.
dc.contributor.authorKang L.
dc.contributor.authorLim C.Y.
dc.contributor.authorPhua K.K.L.
dc.date.accessioned2020-09-04T01:47:12Z
dc.date.available2020-09-04T01:47:12Z
dc.date.issued2018
dc.identifier.citationKoh K.J., Liu Y., Lim S.H., Loh X.J., Kang L., Lim C.Y., Phua K.K.L. (2018). Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Scientific Reports 8 (1) : 11842. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-018-30290-3
dc.identifier.issn2045-2322
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174212
dc.description.abstractIn this paper, we report a proof of concept study on the fabrication, characterization and therapeutic evaluation of in vitro transcribed messenger RNA (mRNA) loaded in a dissolving microneedle patch (RNApatch). We show that low molecular weight polyvinylpyrrolidone (PVP) can directly be used without further purification for RNApatch fabrication with no detectable mRNA degradation. Physical and functional integrity of mRNA stored within the RNApatch are completely preserved for at least 2 weeks under ambient conditions. While the loading of mRNA into RNApatch is limited by the solubility of mRNA in concentrated PVP solution, mechanical strength of RNApatch is not compromised by the presence of mRNA. RNApatch can mediate in vivo transgene expression of mRNA encoding luciferase for up to 72 hours and transfection efficiency and kinetics mediated by RNApatch compares favorably to subcutaneous injection. Interestingly, mRNA transfection efficiency does not correlate with contact surface area but instead increases with deeper delivery depths. In an E.G7-OVA immunotherapy model, RNApatch induces slightly higher cellular and humoral immune responses compared to subcutaneous injection. In conclusion, RNApatch is a viable delivery platform for mRNA and represents an attractive option with significant translation potential for the delivery of mRNA therapeutics. © 2018, The Author(s).
dc.publisherNature Publishing Group
dc.sourceUnpaywall 20200831
dc.subjectmessenger RNA
dc.subjectpolymer
dc.subjectpovidone
dc.subjectanimal
dc.subjectC57BL mouse
dc.subjectchemistry
dc.subjectdevices
dc.subjectdrug delivery system
dc.subjectfemale
dc.subjectgenetics
dc.subjecthuman
dc.subjectimmunotherapy
dc.subjectmicroinjection
dc.subjectneedle
dc.subjectpharmaceutics
dc.subjectprocedures
dc.subjectsolubility
dc.subjectsubcutaneous drug administration
dc.subjecttransdermal patch
dc.subjecttumor cell line
dc.subjectAnimals
dc.subjectCell Line, Tumor
dc.subjectDrug Delivery Systems
dc.subjectFemale
dc.subjectHumans
dc.subjectImmunotherapy
dc.subjectInjections, Subcutaneous
dc.subjectMice, Inbred C57BL
dc.subjectMicroinjections
dc.subjectNeedles
dc.subjectPolymers
dc.subjectPovidone
dc.subjectRNA, Messenger
dc.subjectSolubility
dc.subjectTechnology, Pharmaceutical
dc.subjectTransdermal Patch
dc.typeArticle
dc.contributor.departmentINDUSTRY LIAISON OFFICE
dc.contributor.departmentMATERIALS SCIENCE AND ENGINEERING
dc.contributor.departmentPHARMACY
dc.contributor.departmentCHEMICAL & BIOMOLECULAR ENGINEERING
dc.description.doi10.1038/s41598-018-30290-3
dc.description.sourcetitleScientific Reports
dc.description.volume8
dc.description.issue1
dc.description.page11842
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-018-30290-3.pdf3.39 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.